The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI
Study Details
Study Description
Brief Summary
Presently spermatozoa for ICSI are selected based on morphology and motion, without determining if acrosome reaction (AR) had occurred during sperm preparation or not. Although not critical if the sperm is injected into the ooplasm, the occurrence of AR might might be an indicator of better spermatozoon quality and implantation potential, especially in severe OTA cases. It is impossible with conventional plain optic microscopy used in IVF units to determine in vivo (without fixation) if AR has occurred, and as a result spermatozoa are injected randomly. It is readily possible to distinguish AR+ from AR- spermatozoa using polarized light microscopy due to different bifriengance.
In this study the investigators seek to determine, by a prospective RCT, if selecting only acrosome reacted spermatozoa, in severe OTA cases, will improve the outcome of ICSI and the entire IVF process.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Detailed Description
A prospective RCT to determine the effect of polscope based spermatozoa selection for ICSI.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Spermatozoa election using a polscope AR+ spermatozoa are selected for ICSI using a polscope |
Procedure: Sperm selection by conventional / polarized light microscopy
Selecting spermatozoa for ICSI using conventional and polarized light microscopy
Other Names:
|
Active Comparator: Control Spermatozoa for ICSI are selected based on morphology and motion under conventional light microscopy |
Procedure: Sperm selection by conventional / polarized light microscopy
Selecting spermatozoa for ICSI using conventional and polarized light microscopy
Other Names:
|
Outcome Measures
Primary Outcome Measures
- fertilization rate [24-72 h]
Determine the impact of AR+ spermatozoa selection of fertilization and in vitro embryonic development.
Secondary Outcome Measures
- Clinical pregnancy [up to 6 weeks]
The occurrence of clinical pregnancies in both arms.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Female: normal uterine cavity and ovarian reserve. Male: TMC < 1000000 cells.
Exclusion Criteria:
- Female: Abnormal uterine anatomy, low ovarian reserve, contributing egg factor, PGD.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hadassah University Hospital | Jerusalem | Israel | 91120 |
Sponsors and Collaborators
- Hadassah Medical Organization
Investigators
- Principal Investigator: Yoel Shufaro, MD PhD, HMO
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 013612- HMO-CTIL